VenoStent
PrivateLast Round
Seed Round
May 1, 2026
Total Funding Raised
$32.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VenoStent is a medical device company that develops bioabsorbable vascular wraps to improve outcomes for hemodialysis patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VenoStent Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
VenoStent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 1, 2026 | ||||
| Grant | Jun 27, 2024 | ||||
| Series A Extension | Jun 27, 2024 | ||||
| Series A | Jul 31, 2023 | ||||
| Seed | Feb 23, 2021 | ||||
SAFE | Jun 24, 2020 |
Key People
Founding team and executive leadership
VenoStent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olima Ventures | Seed |
| Good Growth Capital | Series A, Series A Extension |
| IAG Capital Partners | Seed, Series A, Series A Extension |
| NIH RADx | Grant |
| Creative Ventures | Series A, Seed |
| SNR | Series A |
| Norwest Venture Partners | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
$10M raised in Seed Round.
- Jun 27, 2024
$4M round led by Norwest Venture Partners and Good Growth Capital.
VenoStent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VenoStent's valuation, stock price, and market status.